EnteroMedics

EnteroMedics Inc. is the developer of vBloc® Neurometabolic Therapy, delivered by a pacemaker-like device known as the Maestro® Rechargeable System, which is a first-of-its-kind weight loss therapy targeting obesity and obesity-related risk factors such as high blood pressure. vBloc Therapy is a non-anatomical altering or restrictive reversible treatment that enables patients to lose weight safely by helping them reduce hunger, decrease the amount of food consumed during meals, and feel full between meals.